A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors
Clinical trial NCT03077607 · COMPLETED
Trial details
- NCT number
- NCT03077607
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-07
- Primary completion
- 2017-12-19
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.